Literature DB >> 12111764

Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial.

Stephen E Wang1, Primo N Lara, Angie Lee-Ow, Jeanne Reed, Lori R Wang, Patti Palmer, Joseph M Tuscano, Carol M Richman, Laurel Beckett, Ted Wun.   

Abstract

Non-hemolytic transfusion reactions (NHTR) occur in up to 30% of patients receiving platelet transfusions. Premedication with acetaminophen and diphenhydramine is a common strategy to prevent NHTR, but its efficacy has not been studied. In this prospective trial, transfusions in patients receiving pre-storage leukocyte-reduced single-donor apheresis platelets (SDP) were randomized to premedication with either acetaminophen 650 mg PO and diphenhydramine 25 mg IV, or placebo. Fifty-one patients received 98 transfusions. Thirteen patients had 15 NHTR: 15.4% (8/52) in the treatment arm and 15.2% (7/46) in the placebo arm. Premedication prior to transfusion of pre-storage leukocyte reduced SDP does not significantly lower the incidence of NHTR as compared to placebo. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111764     DOI: 10.1002/ajh.10119

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  17 in total

Review 1.  Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?

Authors:  Terrence L Geiger; Scott C Howard
Journal:  Transfus Med Rev       Date:  2007-01

2.  Reactions Induced by Platelet Transfusions.

Authors:  Volker Kiefel
Journal:  Transfus Med Hemother       Date:  2008-09-16       Impact factor: 3.747

3.  Impact of computerized physician order entry alerts on prescribing in older patients.

Authors:  Paula E Lester; Liliana Rios-Rojas; Shahidul Islam; Melissa J Fazzari; Irving H Gomolin
Journal:  Drugs Aging       Date:  2015-03       Impact factor: 3.923

Review 4.  The use of premedications for platelet transfusions in pediatric patients.

Authors:  Meghan McCormick; Darrell Triulzi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 5.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

6.  Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert G Hamilton; Paul M Ness
Journal:  Transfusion       Date:  2011-05-13       Impact factor: 3.157

7.  The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).

Authors:  Aaron A R Tobian; Alice K Fuller; Kristin Uglik; Daniel J Tisch; Prabhakar D Borge; Richard J Benjamin; Paul M Ness; Karen E King
Journal:  Transfusion       Date:  2013-11-19       Impact factor: 3.157

Review 8.  Reducing noninfectious risks of blood transfusion.

Authors:  Brian M Gilliss; Mark R Looney; Michael A Gropper
Journal:  Anesthesiology       Date:  2011-09       Impact factor: 7.892

9.  Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.

Authors:  William J Savage; Aaron A Tobian; Alice K Fuller; Robert A Wood; Karen E King; Paul M Ness
Journal:  Transfusion       Date:  2011-01-07       Impact factor: 3.157

10.  Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert G Hamilton; P Dayand Borge; Richard M Kaufman; Paul M Ness
Journal:  Transfusion       Date:  2014-09-10       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.